Celldex Therapeutics (CLDX) Debt Ratio (2010 - 2013)

Celldex Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.07 for Q1 2013.

• On a quarterly basis, Debt Ratio fell 36.86% year-over-year to 0.07 in Q1 2013; TTM through Mar 2013 was 0.07, a 36.86% decrease from a year earlier, with the FY2012 full-year figure at 0.09, down 41.56% from the prior year.
• Debt Ratio slipped to 0.07 in Q1 2013 per CLDX's latest filing, from 0.09 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.16 in Q2 2012 and bottomed at 0.07 in Q1 2013.
• The 4-year median for Debt Ratio is 0.11 (2012), against an average of 0.12.
• Across the five-year window, Debt Ratio soared 69.91% in 2011 and plunged 41.56% in 2012, its largest moves.
• Year by year, Debt Ratio stood at 0.09 in 2010, then surged by 69.91% to 0.15 in 2011, then plunged by 41.56% to 0.09 in 2012, then dropped by 22.37% to 0.07 in 2013.
• Per Business Quant, the three latest CLDX Debt Ratio figures stand at 0.07 (Q1 2013), 0.09 (Q4 2012), and 0.11 (Q3 2012).